| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥95.5B | ¥92.0B | +3.8% |
| Operating Income | ¥1.4B | ¥0.4B | +240.6% |
| Ordinary Income | ¥2.4B | ¥1.3B | +83.1% |
| Net Income | ¥1.5B | ¥2.1B | -27.1% |
| ROE | 2.1% | 3.0% | - |
FY2026 Q3 cumulative results (9 months ended December 31, 2025): Revenue reached 95.5B yen (YoY +3.8%), Operating Income 1.4B yen (YoY +240.6%), Ordinary Income 2.4B yen (YoY +83.1%), and Net Income 1.5B yen (YoY -27.1%). The company demonstrated substantial operating profit improvement driven by gross margin expansion to 44.4% and effective SG&A control, though operating margin remains modest at 1.4%. The disconnect between operating profit growth (+240.6%) and net income decline (-27.1%) reflects higher tax burden and non-operating factors. Non-operating income contributed approximately 1.0B yen net positive, primarily from dividend income of 0.3B yen and other non-operating income of 0.4B yen. Despite revenue growth momentum continuing, profitability remains structurally challenged with ROE at 2.1%, significantly constrained by thin net profit margin of 1.6%.
Revenue increased 3.5B yen to 95.5B yen, representing 3.8% YoY growth, with Apparel and Accessories segment contributing 79.8B yen and Fragrance segment 15.7B yen. The Apparel and Accessories segment revenue grew 4.5B yen (YoY +5.9%) while Fragrance segment declined 1.0B yen (YoY -6.1%), indicating divergent business momentum. Operating income surged from 0.4B yen to 1.4B yen, driven by gross profit expansion of 1.8B yen despite SG&A expenses increasing 0.8B yen. The gross margin improvement from prior period levels reflects better product mix and pricing optimization. However, SG&A ratio remained elevated at 43.0% of revenue, limiting operational leverage. Ordinary income of 2.4B yen versus operating income of 1.4B yen demonstrates substantial contribution from non-operating items, approximately 1.0B yen net positive. Non-operating income includes dividend income of 0.3B yen, suggesting meaningful investment securities holdings. The ordinary-to-net income gap of 0.9B yen reflects normal tax burden with an effective tax rate of approximately 35.5%. A notable non-recurring factor emerged in the current period: impairment loss of 4.0 million yen was recorded for Fragrance segment direct retail stores, signaling profitability challenges in certain store locations. This represents a revenue-up, profit-up pattern, though absolute profit levels remain modest relative to revenue scale, with operating margin of 1.4% indicating limited pricing power and cost structure efficiency.
The Apparel and Accessories segment generated revenue of 79.8B yen with segment profit of 0.4B yen, representing approximately 83.6% of total revenue and establishing it as the core business. The Fragrance segment recorded revenue of 15.7B yen but incurred a segment loss of 0.1B yen. YoY comparison shows Apparel and Accessories profit improved significantly from 0.3B yen to 0.4B yen (segment profit margin improving to approximately 0.5%), while Fragrance segment loss widened from -0.01B yen to -0.1B yen. The margin differential between segments is substantial: Apparel and Accessories achieved positive profitability while Fragrance remained loss-making, with the latter burdened by direct retail store underperformance requiring impairment recognition. Corporate unallocated costs of 0.1B yen and inventory adjustments also impacted consolidated results. The widening Fragrance segment loss of approximately 0.1B yen warrants attention as a drag on overall profitability, with store-level economics requiring structural review.
[Profitability] ROE of 2.1% remains substantially below industry standards, constrained by net profit margin of 1.6% and asset turnover of 0.75x. Operating margin of 1.4% improved from prior year's 0.4% but remains structurally low, with gross margin of 44.4% absorbed by SG&A ratio of 43.0%. The minimal operating leverage indicates limited pricing power and scale efficiency challenges. [Cash Quality] Cash and deposits of 16.2B yen provide 0.37x coverage of short-term debt (18.0B yen in short-term loans), indicating constrained liquidity buffer. Working capital cycle extended to 174 days (CCC), with inventory turnover of 191 days (DIO 215 days) and receivables collection of 72 days (DSO) highlighting operational inefficiency. [Investment Efficiency] Asset turnover of 0.75x lags typical trading company efficiency, with significant capital tied up in inventory (27.8B yen) and trade receivables (18.9B yen). Investment securities increased 25.8% YoY to 14.5B yen, representing 11.4% of total assets and introducing valuation risk exposure. [Financial Health] Equity ratio of 57.4% demonstrates conservative capitalization, with debt-to-equity ratio of 0.74x maintaining prudent leverage. Current ratio of 157.4% appears adequate, though quick ratio of 93.9% below 100% signals limited immediate liquidity. The short-term liability composition at 85.1% of total liabilities creates refinancing risk, with 43.8B yen in current liabilities versus 16.2B yen cash position.
Cash and deposits increased 0.5B yen YoY to 16.2B yen, though this modest accumulation against operating income improvement of 1.0B yen suggests working capital absorption. Inventory increased 1.4B yen YoY to 27.8B yen, representing significant cash consumption and indicating inventory turnover challenges with days inventory outstanding of 215 days. Trade receivables rose 1.2B yen to 18.9B yen, further constraining cash conversion. On the liability side, trade payables increased 1.3B yen to 16.5B yen, providing partial working capital relief through extended supplier credit. Short-term loans declined 2.8B yen to 18.0B yen while long-term loans increased 1.2B yen to 3.1B yen, indicating debt structure shift toward longer maturity though overall debt decreased modestly. The working capital cycle deterioration, evidenced by 174-day CCC and increasing inventory and receivables levels, constrains operating cash generation despite profit improvement. Cash coverage of short-term liabilities at 0.37x remains tight, with the gap between current assets (68.9B yen) and current liabilities (43.8B yen) providing 25.1B yen working capital cushion, though heavily inventory-dependent.
Ordinary income of 2.4B yen versus operating income of 1.4B yen demonstrates net non-operating contribution of approximately 1.0B yen, representing 1.0% of revenue. This comprises primarily dividend income of 0.3B yen, other non-operating income of 0.4B yen, partially offset by interest expense of 0.2B yen. Non-operating income accounts for a material portion of pre-tax profit (41.7% of ordinary income), indicating reliance on investment income to supplement thin operating margins. The investment securities balance of 14.5B yen generating 0.3B yen in dividends implies yield of approximately 2.1%, with the 25.8% YoY increase in securities holdings suggesting strategic emphasis on investment income. Comprehensive income of 2.8B yen exceeded net income of 1.5B yen by 1.3B yen, primarily driven by valuation gains on securities of 1.2B yen, indicating unrealized investment appreciation supporting book value though not cash earnings. The impairment loss of 4.0 million yen in the Fragrance segment represents a non-recurring charge reflecting store-level asset writedowns. While operating profit improvement is genuine, the heavy contribution from non-operating items and significant unrealized gains raises questions about core earnings sustainability. The absence of disclosed operating cash flow data limits assessment of cash-backed earnings quality, though the extended working capital cycle and rising inventory levels suggest cash conversion lags reported profits.
Against full-year guidance of revenue 134.7B yen and operating income 2.3B yen, Q3 cumulative progress stands at 70.9% for revenue and 59.1% for operating income. Revenue progress of 70.9% at Q3 (standard expectation 75%) trails by 4.1 percentage points, indicating potential full-year shortfall risk or expected Q4 seasonal acceleration. Operating income progress of 59.1% lags the 75% standard benchmark by 15.9 percentage points, suggesting either conservative guidance or backend-loaded profit assumptions. The company forecasts full-year net income of 2.25B yen (EPS 123.28 yen) and dividend of 50.00 yen. Current Q3 cumulative net income of 1.5B yen represents 66.7% progress, lagging standard 75% by 8.3 points. The guided full-year operating margin of 1.7% (2.3B yen / 134.7B yen) implies modest improvement from Q3's 1.4%, requiring Q4 operating margin expansion to approximately 2.4% to achieve guidance. Given Q3 segment trends showing Fragrance segment losses persisting and impairment charges emerging, the operating income guidance may face execution risk. Revenue guidance implies Q4 revenue of 39.2B yen, representing 13.1% sequential growth from Q3's implied quarterly average of 31.8B yen, requiring material seasonal uptick or one-time factors.
The company forecasts annual dividend of 50.00 yen for the fiscal year. Based on forecast EPS of 123.28 yen, the implied payout ratio is 40.6%, within sustainable range. However, based on actual 9-month EPS of 83.96 yen, if full-year EPS tracks closer to current run-rate, the payout ratio would approximate 60% or higher, approaching the sustainability threshold. The dividend of 50.00 yen per share on 1,825,000 average outstanding shares implies total dividend payout of approximately 0.9B yen. Against net income guidance of 2.25B yen, this represents 40.6% payout, but against current 9-month net income of 1.5B yen, the implied full-year payout burden warrants monitoring if profit momentum weakens. No share buyback programs are disclosed. The dividend policy appears maintainable given equity base of 72.8B yen and current cash position of 16.2B yen, though operating cash flow generation capacity remains uncertain given extended working capital cycle. Dividend sustainability hinges on achieving full-year profit guidance and improving cash conversion efficiency.
Structural low profitability with operating margin of 1.4% and net margin of 1.6% limits financial resilience and leaves minimal buffer against revenue volatility or cost inflation. The thin margin structure restricts reinvestment capacity and dividend growth potential, requiring sustained operational efficiency gains to achieve industry-standard profitability.
Working capital inefficiency evidenced by 174-day cash conversion cycle, with inventory turnover at 191 days and 27.8B yen inventory balance representing 29.1% of revenue. Extended inventory holding periods create obsolescence risk and tie up 1.7x the company's cash balance in working capital. The 1.4B yen YoY inventory increase against 3.5B yen revenue growth suggests inventory management deterioration, with DIO of 215 days nearly quadruple the industry median of 56 days.
High short-term liability dependence with 85.1% of liabilities classified as current (43.8B yen), including 18.0B yen in short-term loans. Cash coverage of short-term debt at 0.9x provides minimal buffer, creating refinancing risk if credit conditions tighten. The maturity mismatch between short-term funding and slow-turning working capital (174-day cycle) presents liquidity stress vulnerability.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 2.1% substantially underperforms industry median of 6.4% (2025-Q3, n=19), ranking in bottom quartile. Operating margin of 1.4% trails industry median of 3.2% (IQR 1.7%-4.9%, n=17), while net profit margin of 1.6% falls below median of 2.7% (IQR 1.3%-6.0%, n=19). The company's margin structure indicates significant profitability gap versus peers.
Financial Health: Equity ratio of 57.4% exceeds industry median of 46.4% (IQR 39.6%-52.6%, n=19), demonstrating above-median capitalization strength. Current ratio of 1.57x trails industry median of 1.88x (IQR 1.64x-2.38x, n=15), positioning in lower-middle range for liquidity. The conservative balance sheet partially offsets weak profitability.
Efficiency: Asset turnover of 0.75x underperforms industry median of 1.00x (IQR 0.62-1.20, n=19). Inventory turnover of 191 days significantly lags industry median of 56 days (IQR 42-84 days, n=17), representing critical operational inefficiency. Working capital cycle of 174 days substantially exceeds industry median of 62 days (IQR 39-112 days, n=18), highlighting structural working capital management weakness.
Growth: Revenue growth of 3.8% YoY falls below industry median of 5.0% (IQR -5.0% to 7.8%, n=19), indicating below-median top-line momentum. EPS growth comparison unavailable due to prior period low base effect distortion.
Overall positioning: The company demonstrates below-median profitability and operational efficiency versus trading industry peers, partially offset by stronger-than-median equity capitalization. The inventory turnover gap represents the most material performance differential requiring operational intervention.
(Industry: Trading, comparison based on 2025-Q3 data, n=15-19 companies depending on metric, Source: Proprietary analysis)
Operating profit inflection point achieved with 240.6% YoY improvement, though absolute margin of 1.4% remains structurally low. The gross margin expansion to 44.4% demonstrates pricing power or mix improvement, yet requires further SG&A leverage to reach industry-standard profitability. Sustained margin progression beyond current levels will determine whether recent improvement represents cyclical recovery or structural turnaround.
Working capital deterioration presents critical earnings quality concern, with cash conversion cycle extending to 174 days and inventory turnover at 191 days, both substantially worse than industry norms (industry median CCC 62 days, DIO 56 days). The 27.8B yen inventory balance representing 1.7x cash position and 29% of revenue indicates capital allocation inefficiency. Inventory management improvement represents the most material operational value creation opportunity.
Financial structure shift observed with long-term debt increasing 61.3% to 3.1B yen while short-term loans declined, extending liability maturity. However, 85.1% short-term liability composition and 0.9x cash coverage of short-term debt maintains refinancing risk exposure. The conservative equity ratio of 57.4% provides balance sheet buffer, though free cash flow generation capacity remains uncertain given working capital absorption. Investment securities growth of 25.8% to 14.5B yen generating 0.3B yen dividend income (2.1% yield) reflects strategic emphasis on investment income to supplement thin operating margins, introducing market valuation risk to book value.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.